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Background: An increasing incidence of malignant mesothelioma (MM) cases in patients with low levels of
asbestos exposure suggests the interference of alternative cofactors. SV40 infection was detected, as co-morbidity
factor, only in 22% of asbestos-MM patients from a North-Eastern Italy area. An additional mechanism of injury
related to asbestos exposure in MM development has been recently associated to inflammatory responses,
principally driven by interleukin (IL)-1 beta (ß) activated within the inflammasome complex.
NLRP3 inflammosome has been described as the intracellular sensor for asbestos able to induce inflammasome
activation and IL-1ß secretion while NLRP1 is expressed in lung epithelial cells and alveolar macrophages and
contributes to the immune response and to survival/apoptosis balance. This study proposes to evaluate the impact
of known NLRP3 and NLRP1 polymorphisms in the individual susceptibility to asbestos-induced mesothelioma in
subjects from a hyperendemic area for MM.
Methods: 134 Italian patients with diagnosis of mesothelioma due (MMAE, n=69) or not (MMAF, n=65) to asbestos,
256 healthy Italian blood donors and 101 Italian healthy subjects exposed to asbestos (HCAE) were genotyped for
NLRP1 (rs2670660 and rs12150220) and NLRP3 (rs35829419 and rs10754558) polymorphisms.
Results: While NLRP3 SNPs were not associated to mesothelioma, the NLRP1 rs12150220 allele T was significantly
more frequent in MMAE (0.55) than in HCAE (0.41) (p=0.011; OR=1.79) suggesting a predisponent effect of this
allele on the development of mesothelioma. This effect was amplified when the NLRP1 rs2670660 allele was
combined with the NLRP1 rs12150220 allele (p=0.004; OR=0.52).
Conclusion: Although NLRP3 SNPs was not involved in mesothelioma predisposition, these data proposed NLRP1 as
a novel factor possibly involved in the development of mesothelioma.
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The multistage evolution of pleural malignant mesotheli-
oma (MM) is characterized by the occurrence of patho-
genetic events involving tumorigenic agents and, among
these, the exposure to asbestos fibers results as the main
risk factor [1]. Recently, the observation of an increasing
incidence of mesothelioma cases in patients with low
levels of asbestos exposure suggests a more complex
process probably due to the interference of alternative
cofactors. (i.e. radiation, other mineral fibers, genetic* Correspondence: comar@burlo.trieste.it
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reproduction in any medium, provided the orand viral ones) involved in a complex pathogenic process
whereby genomic damage mechanisms work over a long
latency period [2-6].
Recent studies emphasize the role of the Simian Virus
40 (SV40) and asbestos as co-carcinogens in causing
mesothelioma, lowering the asbestos threshold limit and
the latency period of carcinogenesis [7-14]. Nevertheless,
the broad variability (0% to 100%) in the detection of
SV40 strain in the different cohort of MM affected
patients showed a controversial role of this virus as
causative agent.
In Italy, the vast asbestos consumption is generally
related to occupational origin and restricted to some
geographic area characterized by a higher incident rateal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients characterized by an “ascertained” asbestosis
from an north eastern Italy area hyperendemic for MM,
with a standardized incidence rates 4 time higher than
the national rate (standard population: Italy census,
2001), showed that SV40 were detected in 22.2% of
the patients, but the data was not found statistically
significant [15].
An additional mechanism of injury related to asbestos
exposure in MM development has been recently asso-
ciated to inflammatory responses, principally driven by
interleukin (IL)-1 beta (ß) activated within the inflamma-
some complex [16].
An important role for IL-1ß has been proposed in the
pathogenesis of asbestos-induced mesothelioma because
it regulates human mesothelial cell proliferation [17],
and IL-1ß–driven inflammation is well known to pro-
mote the development and invasiveness of several tumor
types in vivo [18].
The study by Dorset et al. [19] supports the implication
of the Nod-Like Receptor Pyrin domain containing 3
(NLRP3) inflammasome complex in the pulmonary in-
flammatory diseases linked to asbestos and air pollutants.
In addition, polymorphisms in NLRP3 gene have been re-
cently associated with chronic inflammatory diseases,
autoimmune disorders and infections [5,6,10,20,21].
Moreover other two SNPs in NLRP1, a gene that codifying
for another inflammasome receptor, have been recently
reported to contribute to the immune response in lung
epithelial cells and alveolar macrophages [14].
Taking in account the previously reported association
between variants in NLRP3 gene and an impaired IL-1
production as well as the role of IL-1 driven inflamma-
tion in asbestos lung fibrosis and mesothelioma, the aim
of this study was to evaluate the impact of the NLRP3
and NLRP1 polymorphisms in the individual susceptibil-
ity to asbestos-induced mesothelioma in a cohort of
MM patients from a North-Eastern Italy area hyperen-
demic for malignant pleural mesothelioma. For compari-
son a series of healthy subjects from the same area at
higher risk for environmental and domestic exposure to
asbestos and a group of healthy subjects not exposed to
asbestos were included as reference control groups.
Results
We analyzed NLRP3 rs35829419, rs10754558 SNPs and
NLRP1 rs2670660, rs12150220 SNPs in 134 Italian
patients with mesothelioma, in 256 healthy controls and
in 101 individuals exposed to asbestos with no meso-
thelioma at the age of the enrollment. SNPs frequencies
were in Hardy–Weinberg equilibrium in all the groups.
The rs2670660 and rs12150220 NLRP1 SNPs as well as
rs35829419 and rs10754558 NLRP3 were not in linkage
disequilibrium in all the tested groups (r2<0.9).The four SNPs were not significantly different distrib-
uted in mesothelioma patients when compared to
healthy controls as reported in Table 1.
When we considered asbestos exposure, the two NLRP3
SNPs were not associated to the development of the can-
cer. The NLRP1 rs2670660 G allele was more frequent in
MMAE than in HCAE (0.55 versus 0.43), although not
significant different after Bonferroni correction (p=0.027).
The NLRP1 rs12150220 T allele was significantly more
frequent in MMAE patients (0.55) than in HCAE (0.41)
(p=0.011; OR=1.79; 95%CI=1.13-2.85) (Table 2).
The NLRP1 SNPs combined to form 4 haplotypes
which showed a significantly different distribution be-
tween MMAE and HCAE (p=0.006) (Table 2). In par-
ticular the haplotype A–A SNPs was significantly less
frequent in MMAE patients than in HCAE (0.40 versus
0.56; p=0.004; OR=0.52; 95% CI=0.33-0.83).
Comparing the two groups of mesothelioma patients
(exposed and not exposed to asbestos), no significant
difference was observed for all the 4 SNPs as reported in
Table 3.
Discussion
Exposure to asbestos is considered the major risk factor
for the onset of MM although its contribution to the
pathogenesis is multifaceted and different cofactors exist
[1,22]. Asbestos induces DNA alterations mostly by in-
ducing mesothelial cells and reactive macrophages to se-
crete mutagenic oxygen and nitrogen species. In
addition, asbestos carcinogenesis is linked to the chronic
inflammatory process caused by the deposition of a suf-
ficient number of asbestos fibres and the consequent re-
lease of pro-inflammatory molecules [23]. Genetic
predisposition, radiation exposureand viral infection are
co-factors that can cause MM alone or in association
with asbestos and recently also with erionite, an environ-
mental contaminant originating from the volcanic Rocks
in Turkey [24].
In a previous study we have reported the presence of
SV40 in 22% of MM patients from a North-Eastern Italy
area massively exposed to asbestos in the past, suggest-
ing that an association between SV40 infection and as-
bestos exposure, as co-morbidity factor, seem to exist
[15]. Nevertheless, SV40 infection was reviled only for a
small group of patients exposed to asbestos reinforcing
the concept that alternative individual host factors could
be involved in MM development.
In this study we considered the hypothesis of an asso-
ciation between known NLRP3 single nucleotide varia-
tions and asbestos-induced mesothelioma.
NLRP3-inflammasome is known to play an important
role in cancer cell transformation [25] and in the im-
mune response against tumors [22,26] and has been
described as the intracellular sensor of asbestos [19].
Table 1 NLRP3 and NLRP1 allele, genotype and haplotypes frequencies in mesothelioma patients (MM) and healthy
controls (HC)
MM (n=134) HC (N=256) P OR (95% CI)
NLRP3 rs35829419 Allele/ Genotype
A 10 (0.04) 30 (0.06)
C 258 (0.96) 482 (0.94) 0.234 1.61 0.75-3.74
A/A 0 0
C/A 10 (0.07) 30 (0.12)
C/C 124 (0.93) 226 (0.88) 0.221
NLRP3 rs10754558 Allele/ Genotype
G 113 (0.42) 232 (0.45)
C 155 (0.58) 280 (0.55) 0.405 1.14 0.83-1.55
G/G 23 (0.17) 55 (0.21)
C/G 67 (0.50) 122 (0.48)
C/C 44 (0.33) 79 (0.31) 0.610
rs35829419-rs10754558 Haplotypes
C-C 153 (0.57) 282 (0.55) 0.459
C-G 107 (0.40) 205 (0.40)
A-G 8 (0.03) 25 (0.05)
NLRP1 rs2670660 Allele/ Genotype
A 131 (0.49) 235 (0.46)
G 137 (0.51) 277 (0.54) 0.450 0.89 0.65-1.2
A/A 33 (0.25) 52 (0.20)
A/G 66 (0.49) 131 (0.51)
G/G 35 (0.26) 73 (0.29) 0.604
NLRP1 rs12150220 Allele/ Genotype
A 133 (0.50) 249 (0.49)
T 135 (0.50) 263 (0.51) 0.821 0.95 0.71-1.31
AA 31 (0.23) 60 (0.23)
AT 72 (0.54) 129 (0.50)
TT 31 (0.23) 67 (0.26) 0.772
rs2670660-rs12150220 Haplotypes
G-T 121 (0.45) 236 (0.46) 0.588
A-A 118 (0.44) 205 (0.40)
G-A 16 (0.06) 41 (0.08)
A-T 13 (0.05) 30 (0.06)
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to activate the inflammasome and IL-1ß secretion, could
affect the response to asbestos, the entity of asbestos-
induced inflammation and, finally, the predisposition to
develop mesothelioma.
Data from our study did not support this hypothesis
because the two SNPs analyzed in NLRP3 gene were not
found associated with mesothelioma (Table 1) or with
asbestos-induced mesothelioma (Table 3). Although the
two analyzed NLRP3 SNPs were already successfully
used to associate this gene to various diseases such asautoimmune (type 1 diabetes, celiac disease, SLE) [6] or
infectious diseases (HIV-1) [10], it is possible that they
could not be totally representative of the entire gene and
deeper investigation will be needed to definitively ex-
clude the association between NLRP3 and asbestos-
induced mesothelioma.
Nevertheless, our findings disclosed a novel hypothesis
about NLR involvement in the development of meso-
thelioma due to asbestos. Notably, our data showed that
the rs2670660 and rs12150220 polymorphisms in NLRP1
gene were not associated to the mesothelioma. (Table 2)
Table 2 NLRP3 and NLRP1 allele, genotype and haplotypes frequencies in mesothelioma patients and controls exposed
to asbestos (MMAE vs HCAE)
MMAE (N=69) HCAE (n=101) p OR (95% CI)
NLRP3 rs35829419 Allele/ Genotype
A 7 (0.05) 10 (0.05)
C 131 (0.95) 192 (0.95) 1 0.97 0.32-3.10
A/A 0 0
C/A 7 (0.10) 10 (0.09)
C/C 62 (0.90) 91 (0.91) 1
NLRP3 rs10754558 Allele/ Genotype
G 58 (0.42) 82 (0.41)
C 80 (0.58) 120 (0.59) 0.823 0.94 0.59-1.50
G/G 11 (0.16) 13 (0.13)
C/G 36 (0.53) 56 (0.55)
C/C 22 (0.31) 32 (0.32) 0.842
rs35829419-rs10754558 Haplotypes
C-C 80 (0.58) 119 (0.59) 0.908
C-G 51 (0.37) 75 (0.37)
A-G 7 (0.05) 8 (0.04)
NLRP1 rs2670660 Allele genotype
A 62 (0.45) 116 (0.57)
G 76 (0.55) 86 (0.43) 0.027 1.65 1.04-2.62
A/A 12 (0.18) 30 (0.30)
A/G 38 (0.54) 56 (0.55)
G/G 19 (0.28) 15 (0.15) 0.059
NLRP1 rs12150220 Allele/ genotype
A 62 (0.45) 120 (0.59)
T 76 (0.55) 82 (0.41) 0.011 1.79 1.13-2.85
A/A 11 (0.16) 32 (0.32)
A/T 41 (0.59) 56 (0.55)
T/T 17 (0.25) 13 (0.13) 0.027
T/T (A/T+A/A) 0.065 2.20 0.92-5.37
(T/T+A/T) A/A 0.030 2.43 1.08-5.84
rs2670660-rs12150220 Haplotypes
A-A* 51 (0.40) 114 (0.56) 0.006 *0.004 *0.52 *(0.33-0.83)
G-T 63 (0.50) 80 (0.40)
G-A 6 (0.05) 6 (0.03)
A-T 6 (0.05) 2 (0.01)
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effect of NLRP1 to cancer development: this could be
explained considering the distribution of NLRP1
throughout the body and the unique role of NLRP1 in
apoptosis. According to Kummer [14], NLRP1, and not
NLRP3, is expressed in lung in both epithelial cells and
alveolar macrophages where NLRP1 inflammasome
possibly act as the major danger-sensing platform. The
deregulation of NLRP1 inflammasome could contributeto the formation of the pro-tumor micro-environment
both influencing the transformation of the lung tissue
cells and/or inducing high levels of IL-1ß that contrib-
ute to growth and metastatic spread in experimental
and human cancers [27-29]. The anti-apoptotic pro-
teins Bcl-2 and Bcl-XL inhibit NLRP1 in a
concentration-dependent manner [16]. It could be
hypothesized that the rs2670660 G allele and
rs12150220 T allele affect the level of NLRP1
Table 3 NLRP3 and NLRP1 allele, genotype and haplotypes frequencies in mesothelioma patients exposed and not
exposed to asbestos (MMAE vs MMAF)
MMAE (N=69) MMAF (n=65) p OR (95% CI)
NLRP3 rs35829419 Allele/ Genotype
A 7 (0.05) 3 (0.02)
C 131 (0.95) 127 (0.98) 0.337 0.44 0.07-1.99
A/A 0 0
C/A 7 (0.10) 3 (0.05)
C/C 62 (0.90) 62 (0.95) 0.327
NLRP3 rs10754558 Allele/ Genotype
G 58 (0.42) 56 (0.43)
C 80 (0.58) 74 (0.57) 0.902 1.04 0.62-1.74
G/G 11 (0.16) 12 (0.19)
C/G 36 (0.53) 32 (0.47)
C/C 22 (0.31) 21 (0.34) 0.946
rs35829419-rs10754558 Haplotypes
C-C 80 (0.58) 73 (0.56) 0.453
C-G 51 (0.37) 53 (0.41)
A-G 7 (0.05) 3 (0.01)
NLRP1 rs2670660 Allele/ genotype
A 62 (0.45) 70 (0.54)
G 76 (0.55) 60 (0.46) 0.179 1.43 0.86-2.40
A/A 12 (0.18) 21 (0.32)
A/G 38 (0.54) 28 (0.44)
G/G 19 (0.28) 16 (0.24) 0.138
NLRP1 rs12150220 Allele/ genotype
A 62 (0.45) 71 (0.55)
T 76 (0.55) 59 (0.45) 0.142 1.47 0.89-2.46
A/A 11 (0.16) 20 (0.31)
A/T 41 (0.59) 31 (0.48)
T/T 17 (0.25) 14 (0.22) 0.146
rs2670660-rs12150220 Haplotypes
A.A 51 (0.40) 53 (0.41) 0.919
G-T 63 (0.50) 62 (0.48)
G-A 6 (0.05) 9 (0.07)
A-T 6 (0.05) 6 (0.05)
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surviving and apoptosis after injury influencing the
mechanism of cell transformation.
Although the frequency of rs2670660 and rs12150220
polymorphism in the general population is relatively
high, it does not exist any functional information about
this variant. We are aware that our results are prelimin-
ary and deeper investigation will be needed to prove
these pathogenic hypothesis. However we believe that
this strong association between the rs12150220 poly-
morphism in NLRP1 and asbestos-mesotheliomadevelopment emphasizes once more the role of inflam-
mation and inflammasome in tumorigenesis events.
Material and methods
Samples
One hundred and thirty four blood samples from
selected incident cases of Caucasian patients from north
eastern Italy areas (Trieste, Ferrara) with malignant
pleural mesothelioma were collected in the period
2009–2011 (112 males/22 females; average age 66 (SD
13) years). Of these, 69 showed an ascertained
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no documented history of asbestos exposure (MMAF).
In addition, blood samples were collected from 101
healthy subjects (84 males/17 females; average age 44 ±
12 yrs) from the same area with previous risk of environ-
mental asbestos exposure (HCAE) and from 256 healthy
blood donors (HC; 118 males/138 females; average age
42 ± 7) not related to the geographic area of patients’
group, were analyzed as controls.
Histological examination and classification of tumor
were performed according to the World Health
Organization criteria [30]. All tumor samples contained
a vast majority of malignant cells and minimal stromal,
inflammatory or otherwise non-malignant cells or nec-
rotic debris. In addition, histological data on the pres-
ence of asbestos fibres (expressed as number /g of dry
lung tissue) were also available (range: from 2 to 164.000
asbestos bodies).
The information about asbestos exposure, were
obtained using the records of the certified Local Meso-
thelioma Registry, affiliated to the Italian National Meso-
thelioma Registry (ReNaM).
The study was approved by the Ethical Committee of
the University Hospital “Ospedali Riuniti di Trieste”
(Trieste, Italy).
DNA extraction
Genomic DNA was extracted from peripheral whole
blood using the EZ1 DNA purification kit (Qiagen.
Milan) following manufacturer’s protocols.
SNPs selection and genotyping
We analyzed 2 SNPs (rs35829419 and rs10754558) in
NLRP3 and 2 SNP (rs2670660 and rs12150220) in the
NLRP1 genes. SNPs genotyping was performed using
commercially available TaqMan assays (Applied Biosys-
tems. Foster City. CA). TaqMan reactions were set up
based on the manufacturer’s protocol and the samples
were run on the ABI7900HT Real-Time PCR platform
(Applied Biosystems). Allelic discrimination was per-
formed as suggested by the manufacturer and analyzed
using the SDS software (v. 2.3) (Applied Biosystems).
Statistical analysis
Allelic and genotypic SNP frequencies were calculated
using the Genotype Transposer software [31] and then
analyzed by Fisher exact test. The Haploview software
[32] was used to investigate the association and linkage
disequilibrium pattern and for deriving the haplotypes.
The open-source R package (http://www.r-project.org)
was used for Fisher exact test and odds ratio (OR) esti-
mation. A formal Bonferroni adjustment for the number
of the tests performed would require a significance
threshold of p=0.013 (p0/N, p0=0.05, N=4 SNP).Dominant/recessive model has been analyzed according
to Lewis [33]. Unadjusted p-values are reported in the
text and tables.
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